About Bromocriptine Mesilate (Mesylate)
            
            Class: | Dopamine agonist  
Use: | Treatment of Parkinson's disease, hyperprolactinemia, and acromegaly; also used off-label for type 2 diabetes and certain menstrual disorders.  
Adult dose: | Initial dose of 1.25 mg to 2.5 mg once daily, may be increased gradually to a maximum of 20 mg per day based on clinical response.  
Pediatric dose: | Not established; use in pediatric patients should be determined by a healthcare provider based on individual circumstances.  
Side effects: | Nausea, vomit
         
        
            
                
                
                    
                        Drug Class
                    
                    Dopamine agonist
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of Parkinson's disease, hyperprolactinemia, and acromegaly; also used off-label for type 2 diabetes and certain menstrual disorders.
                 
                
                
                    
                        Storage Requirements
                    
                    Store at room temperature (15°C to 30°C or 59°F to 86°F) in a tightly closed container, protected from light and moisture.
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Amoun Pharmaceutical Co.S.A.E., EGYPT
                    
                    
                    Package Size
                    20's Plastic Bottle
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 4.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Initial dose of 1.25 mg to 2.5 mg once daily, may be increased gradually to a maximum of 20 mg per day based on clinical response.
                    
                    
                        Pediatric Dose
                    
                    
                        Not established; use in pediatric patients should be determined by a healthcare provider based on individual circumstances.
                    
                 
                
                
                    
                        Side Effects
                    
                    Nausea, vomiting, dizziness, headache, fatigue, orthostatic hypotension, and gastrointestinal disturbances.
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to bromocriptine or any component of the formulation; uncontrolled hypertension; pregnancy (unless used for specific indications under medical supervision).
         
        
        
            
                Important Warnings
            
            Risk of serious cardiovascular events in patients with pre-existing cardiovascular disease; may cause hallucinations or psychotic disorders; caution in patients with a history of severe mental illness.
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.